Home > Qtrly Results > NEULAND LABORATORIES

NEULAND LABORATORIES
Quarterly Results Analysis [Mar2025]

NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Quarterly Results

Consolidated Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
Audited
Jun2023
UnAudited
Revenues ₹328 Cr ₹398 Cr ₹311 Cr ₹440 Cr ₹385 Cr ₹393 Cr ₹418 Cr ₹363 Cr
Expenses ₹277 Cr ₹311 Cr ₹249 Cr ₹316 Cr ₹278 Cr ₹272 Cr ₹280 Cr ₹266 Cr
Operating Income ₹51 Cr ₹87 Cr ₹62 Cr ₹123 Cr ₹107 Cr ₹121 Cr ₹137 Cr ₹97 Cr
Other Income ₹7 Cr ₹4 Cr ₹4 Cr ₹5 Cr ₹5 Cr ₹2 Cr ₹3 Cr ₹2 Cr
Interest ₹2 Cr ₹2 Cr ₹1 Cr ₹3 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹2 Cr
Depreciation ₹17 Cr ₹16 Cr ₹16 Cr ₹16 Cr ₹16 Cr ₹15 Cr ₹15 Cr ₹14 Cr
Profit Before Tax ₹39 Cr ₹128 Cr ₹49 Cr ₹130 Cr ₹92 Cr ₹104 Cr ₹122 Cr ₹83 Cr
Profit After Tax ₹28 Cr ₹102 Cr ₹33 Cr ₹98 Cr ₹68 Cr ₹81 Cr ₹89 Cr ₹62 Cr
EPS ₹21.56 ₹78.75 ₹25.46 ₹75.86 ₹52.37 ₹63.09 ₹69.18 ₹47.96
Industry Peers & Returns1W1M1Y
NEULAND LABORATORIES 0.2% 1.5% 58.7%
SUN PHARMACEUTICAL INDUSTRIES 0.5% 0.6% 9.5%
DIVIS LABORATORIES 3.7% 5.1% 49.1%
CIPLA -1% 1.7% 2.4%
TORRENT PHARMACEUTICALS 3.8% 6.8% 22.5%
DR REDDYS LABORATORIES -3.7% 1.9% -0.3%
MANKIND PHARMA 3.6% 1.5% 7.5%
ZYDUS LIFESCIENCES 1.4% 7.5% -6.8%
LUPIN 2.2% 0.7% 21%

NEULAND LABORATORIES Quarterly Revenues

Revenues
Q-o-Q

-17.50 %

Y-o-Y

-14.71 %

Quarters Revenues % Change
Mar2025 ₹328 Cr
-17.50
Dec2024 ₹398 Cr
28.05
Sep2024 ₹311 Cr
-29.29
Jun2024 ₹440 Cr
14.18
Mar2024 ₹385 Cr
-1.99
Dec2023 ₹393 Cr
-5.97
Sep2023 ₹418 Cr
15.08
Jun2023 ₹363 Cr -

NEULAND LABORATORIES Quarterly Operating Profit

Operating Profit
Q-o-Q

-41.02 %

Y-o-Y

-52.23 %

Quarters Operating Profit % Change
Mar2025 ₹51 Cr
-41.02
Dec2024 ₹87 Cr
39.16
Sep2024 ₹62 Cr
-49.56
Jun2024 ₹123 Cr
15.38
Mar2024 ₹107 Cr
-11.83
Dec2023 ₹121 Cr
-11.80
Sep2023 ₹137 Cr
41.86
Jun2023 ₹97 Cr -
Operating Margins
Q-o-Q

-28.54 %

Y-o-Y

-44.00 %

Quarters Operating Margin% % Change
Mar2025 15.55%
-28.54
Dec2024 21.76%
8.69
Sep2024 20.02%
-28.65
Jun2024 28.06%
1.04
Mar2024 27.77%
-10.04
Dec2023 30.87%
-6.20
Sep2023 32.91%
23.26
Jun2023 26.7% -

NEULAND LABORATORIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-72.63 %

Y-o-Y

-58.84 %

Quarters Profit After Tax % Change
Mar2025 ₹28 Cr
-72.63
Dec2024 ₹102 Cr
209.32
Sep2024 ₹33 Cr
-66.44
Jun2024 ₹98 Cr
44.86
Mar2024 ₹68 Cr
-16.99
Dec2023 ₹81 Cr
-8.80
Sep2023 ₹89 Cr
44.23
Jun2023 ₹62 Cr -
PAT Margins
Q-o-Q

-66.81 %

Y-o-Y

-51.74 %

Quarters PAT Margin(%) % Change
Mar2025 8.47 %
-66.81
Dec2024 25.52 %
141.44
Sep2024 10.57 %
-52.52
Jun2024 22.26 %
26.84
Mar2024 17.55 %
-15.30
Dec2023 20.72 %
-3.00
Sep2023 21.36 %
25.28
Jun2023 17.05 % -

NEULAND LABORATORIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-72.62 %

Y-o-Y

-58.83 %

Quarters EPS % Change
Mar2025 ₹21.56
-72.62
Dec2024 ₹78.75
209.31
Sep2024 ₹25.46
-66.44
Jun2024 ₹75.86
44.85
Mar2024 ₹52.37
-16.99
Dec2023 ₹63.09
-8.80
Sep2023 ₹69.18
44.25
Jun2023 ₹47.96 -

You may also like the below Video Courses